VERA Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Vera Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 43.5 USD 2.79%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast VERA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VERA is 49.85 USD with a low forecast of 25.25 USD and a high forecast of 63 USD.

VERA Lowest Forecast

Wall Street Target

VERA Average Forecast

Wall Street Target

VERA Highest Forecast

Wall Street Target

42% Downside

15% Upside

45% Upside

The latest public price target was made on Mar 21, 2024 by Laura Chico from Wedbush , who expects VERA stock to drop by 22% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Laura Chico Wedbush	34 USD Downside 22%	1 month ago Mar 21, 2024	Vera Therapeutics (VERA) PT Raised to $34 at Wedbush StreetInsider
Ryan Deschner Raymond James	29 USD Downside 33%	4 months ago Dec 18, 2023	Vera Therapeutics' Kidney Disease Drug Has Opportunity In A Competitive Development Landscape: Analyst Benzinga

Price Target	34 USD
Upside/Downside	22%

Price Target	29 USD
Upside/Downside	33%

Alnylam Pharmaceuticals Inc

51% Upside

Immatics NV

75% Upside

Shanghai MicuRx Pharmaceutical Co Ltd

71% Upside

Entrada Therapeutics Inc

58% Upside

Alnylam Pharmaceuticals Inc

51% Upside

Immatics NV

75% Upside

Shanghai MicuRx Pharmaceutical Co Ltd

71% Upside

Entrada Therapeutics Inc

58% Upside

Changchun BCHT Biotechnology Co

62% Upside

Rallybio Corp

589% Upside

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

12% Upside

BridgeBio Pharma Inc

83% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

9%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-49%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for VERA is 49.85 USD with a low forecast of 25.25 USD and a high forecast of 63 USD.

Join more than 133,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.